Dihaloplatinum(II) complexes having diimine ligands: crystal structure,thermal properties,cytotoxicity effects against breast cancer cells and application as a precursor towards nanoparticles

The reaction of potassium tetrachloroplatinate(II) with dimethylsulfide and a mixture of HBr/KBr affords trans-[PtBr₂(SMe₂)₂]; [PtBr₂(Me₂bpy)] (Me₂bpy = 4,4'-dimethyl-2,2'-bipyridine) was prepared from the reaction of trans-[PtBr₂(SMe₂)₂] with Me₂bpy. The crystal structure of the yellow form of [PtBr₂(bu₂bpy)] (bu₂bpy = 4,4'-di-tert-butyl-2,2'-bipyridine) was determined by X-ray crystallography. The X-ray single-crystal structure determination of complex [PtBr₂(bu₂bpy)] reveals that the platinum adopts a square planar geometry with a twofold axis through the platinum atoms. Thermal properties of the related series of diimine platinum(II) complexes [PtX₂(bu₂bpy)] (X?=?Cl, Br, I) reveal that the thermal stabilities increase [PtI₂(bu₂bpy)]?<?[PtCl₂(bu₂bpy)]?<?[PtBr₂(bu₂bpy)]. [PtBr₂(bpy)] (bpy = 2,2'-bipyridine), [PtBr₂(Me₂bpy)] and [PtX₂(bu₂bpy)] (X?=?Cl, Br, I) were studied by MTT assay against two human breast cancer cell lines of MCF-7 and MDA-MB-468 with [PtCl₂(bu₂bpy)] having a higher cytotoxic effect towards both cancer cell lines, which shows the significant role of the halide and diimine ligand. Semi-spherical Pt(0) nanoparticles (NPCs) were prepared by the simple calcination of [PtX₂(bu₂bpy)] (X?=?Cl, Br, I) at 800?°C in air.     

Complexes of Pt(II) and Pt(IV) with disubstituted purines

Mixed-ligand complexes of Pt(II) and Pt(IV) with 2,6-diaminopurine and 6-thioguanine were synthesized and characterised. The complexes were prepared in acidic and basic media. The binding of the ligands to the metal ion varies according to the pH of the medium. Thus, in the complexes of 6-thioguanine, the ligand acts as a monodentate ligand coordinating through the neutral C₆-SH group in the acidic medium and in the basic medium as a bidentate ligand binding to the metal ion through C₆S^? and N₇, forming a five-membered chelate ring. In an acidic medium 2,6-diaminopurine forms mononuclear complexes with Pt(II) and Pt(IV) binding through N₇. In a basic medium binuclear hydroxobridged complexes are formed with Pt(IV) and the ligand is monodentate, coordinating through N₇.     

Biological studies and computational modeling of two new copper complexes derived from β-diketones and their nano-complexes

Abstract

The present study was conducted to design and develop new complexes and their metal-based nanodrug (registered as Casiopeínas^® for cancer) with a low toxicity, high efficiency, and high selectivity. First, complexes ([Cu(TTA)(bpy)₂] (1) and [Cu(TTA)₂(en)] (2) (TTA = 4,4,4-trifluoro-1-(2-furyl)-1,3-butanedione) were synthesized and characterized by X-ray diffraction studies, CHN analysis, conductivity measurements, FT-IR and UV-vis spectroscopy. Second, nanoparticles (NPs) of 3 and 4 with the average size of 63.04 and 85.39?nm were prepared with ultrasound. Scanning electron microscopy patterns of 3 and 4 showed irregular spherical and nanorod particles with spongy surface. Furthermore, the anticancer properties of compounds and nano-compounds were studied in MKN-45 cell line. Then, apoptosis studies were carried out utilizing AO/EB staining methods. Finally, to confirm the in vitro experimental data, the theoretical study was carried out by molecular docking studies. The results of DNA docking analysis revealed that 1 and 2 were inserted with DNA via the minor groove. The binding affinity monitors the order of 1?>?2, with a preference of binding to A-T over G-C base pairs sequences.     

The Anticancer Activity and HSA Binding Properties of the Structurally Related Platinum (II) Complexes

The development of resistance and unwanted harmful interaction with other biomolecules instead of DNA are the major drawbacks for application of platinum (Pt) complexes in cancer chemotherapy. To conquer these problems, much works have been done so far to discover innovative Pt complexes. The objective of the current study was to evaluate the anti cancer activities of a series of four and five-coordinated Pt(II) complexes, having deprotonated 2-phenyl pyridine (abbreviated as C^N), biphosphine moieties, i.e., dppm?=?bis(diphenylphosphino) methane (Ph₂PCH₂PPh₂) and dppa?=?bis(diphenylphosphino)amine (Ph₂PNHPPh₂), as the non-leaving carrier groups. The growth inhibitory effect of the Pt complexes [Pt(C^N)(dppm)]PF₆: C ₁ , [Pt(C^N)(dppa)]PF₆: C ₂ , and [Pt(C^N)I(dppa)]: C ₃ , toward the cancer cell lines was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. In addition, the florescence quenching experiments of the interaction between human serum albumin (HSA) and the Pt complexes were performed in order to obtain the binding parameters and to evaluate the denaturing properties of these complexes upon binding to the general carrier protein of blood stream. The structure?Cactivity relationship studies reveal that four-coordinated Pt complexes C ₁ and C ₂ with both significant hydrophobic and charge characteristics, not only exhibit strong antiproliferation activity toward the cancer cell lines, but also they display lower denaturing effect against carrier protein HSA. On the other hand, five-coordinated C ₃ complex with the unusual intermolecular NH??Pt hydrogen binding and the intrinsic ability for oligomerization, exhibits poor anticancer activity and strong denaturing property. The current study reveals that the balance between charge and hydrophobicity of the Pt complexes, also their hydrogen binding abilities and coordination mode are important for their anticancer activities. Moreover, this study may suggest C ₁ and C ₂ as the potential template structures for synthesis of new generation of four-coordinated Pt complexes with strong anticancer activities and weak denaturing effects against proteins.     

Synthesis and characterization of some organotin(IV) adducts containing a related series of pyridines: Crystal structure of [SnMe2Cl2(bu2bpy)]

Organotin(IV) complexes of [SnR_(4−n)Cl_n] (n = 2, R = Me, ⁿBu; n = 1, R = Ph) react with the bidentate pyridyl ligand 4,4′-di-tert-butyl-2,2′-bipyridine (bu₂bpy) to give hexa-coordinated adducts with the general formula [SnR_(4−n)Cl_n(bu₂bpy)]. However, the reaction of these organotin(IV) complexes with the corresponding monodentate ligand 4-tert-butylpyridine (bupy) resulted in the formation of the hexa-coordinated complex [SnMe₂Cl₂(bupy)₂] and the penta-coordinated complexes [SnR_(4−n)Cl_n(bupy)] (n = 2, R = ⁿBu; n = 1, R = Ph). Moreover, the reaction of the above organotin(IV) complexes with 4,4′-trimethylenedipyridine (tmdp) yields hexa-coordinated adducts with the general formula [SnR₂Cl₂(tmdp)] (R = Me, ⁿBu) and the penta-coordinated complex [ClPh₃Sn-μ-(tmdp)SnPh₃Cl] in the solid state. The resulting complexes have been characterized by multinuclear NMR (¹H, ¹³C, ¹¹⁹Sn) spectroscopy and elemental analysis. NMR data shows that the triphenyltin(IV) adducts are not stable in solution and dissociate to give tetra-coordinated tin(IV) complexes. The X-ray crystal structure determination of [SnMe₂Cl₂(bu₂bpy)] reveals that the tin atom is hexa-coordinated in an octahedral geometry with a trans-[SnMe₂] configuration.     

Photolysis and Thermolysis of Platinum(IV) 2,2′‐Bipyridine Complexes Lead to Identical Platinum(II)–DNA Adducts

Two Pt^IV and two Pt^II complexes containing a 2,2′‐bipyridine ligand were treated with a short DNA oligonucleotide under light irradiation at 37 °C or in the dark at 37 and 50 °C. Photolysis and thermolysis of the Pt^IV complexes led to spontaneous reduction of the Pt^IV to the corresponding Pt^II complexes and to binding of Pt^II 2,2′‐bipyridine complexes to N7 of guanine. When the reduction product was [Pt(bpy)Cl₂], formation of bis‐oligonucleotide adducts was observed, whereas [Pt(bpy)(MeNH₂)Cl]⁺ gave monoadducts, with chloride ligands substituted in both cases. Neither in the dark nor under light irradiation was the reductive elimination process of these Pt^IV complexes accompanied by oxidative DNA damage. This work raises the question of the stability of photoactivatable Pt^IV complexes toward moderate heating conditions.     

Novel 2,2′-bipyridine palladium(II) complexes with glycine derivatives: synthesis, characterization, cytotoxic assays and DNA-binding studies

The two water-soluble designed palladium(II) complexes, [Pd(bpy)(pip-Ac)]NO₃ and [Pd(bpy)(mor-Ac)]NO₃, (where bpy is 2,2′-bipyridine, pip-Ac is 1-piperidineacetato and mor-Ac is 4-morpholineacetato) have been synthesized and characterized by elemental analyses, molar conductivity measurements and spectroscopic methods (FT-IR, ¹H NMR, UV–Vis). The complexes have been tested for in vitro cytotoxic activity against human breast cancer cell line, T47D. The binding of these complexes with DNA has been investigated by absorption spectroscopy, fluorescence titration spectra, EB displacement and gel chromatography. The results suggest that the complexes can bind to DNA cooperatively through a static mechanism at low concentrations (~0.57 μM). The thermodynamic parameters indicated that the van der Waals and hydrogen binding might play a major role in the interaction of these complexes with DNA.     

Synthesis,Characterization, and DNA‐Binding Properties of the Chiral Ruthenium(II) Complexes Δ‐ and Λ‐[Ru(bpy)2(dmppd)]2+ (dmppd = 10,12‐Dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10H,12H)‐dione; bpy = 2,2′‐Bipyridine)

Two novel chiral ruthenium(II) complexes, Δ‐[Ru(bpy)₂(dmppd)]²⁺ and Λ‐[Ru(bpy)₂(dmppd)]²⁺ (dmppd = 10,12‐dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10H,12H)‐dione, bpy = 2,2′‐bipyridine), were synthesized and characterized by elemental analysis, ¹H‐NMR and ES‐MS. The DNA‐binding behaviors of both complexes were studied by UV/VIS absorption titration, competitive binding experiments, viscosity measurements, thermal DNA denaturation, and circular‐dichroism spectra. The results indicate that both chiral complexes bind to calf‐thymus DNA in an intercalative mode, and the Δ enantiomer shows larger DNA affinity than the Λ enantiomer does. Theoretical‐calculation studies for the DNA‐binding behaviors of these complexes were carried out by the density‐functional‐theory method. The mechanism involved in the regulating and controlling of the DNA‐binding abilities of the complexes was further explored by the comparative studies of [Ru(bpy)₂(dmppd)]²⁺ and of its parent complex [Ru(bpy)₂(ppd)]²⁺ (ppd = pteridino[6,7‐f] [1,10]phenanthroline‐11,13 (10H,12H)‐dione).     

Absorption Spectra and Luminescence Properties of Isomeric Platinum (II) and Palladium (II) Complexes containing 1,1′-biphenyldiyl, 2-phenylpyridine,and 2,2′-bijpyridine as ligands

The absorption spectra, luminescence spectra, and luminescence lifetimes of the isomeric [M(bph)(bpy)] and [M(phpy)₂] complexes M = Pt(II) or Pd(II), bph^2? = 1,1′-biphenyl-2,2′-diyl dianion, phpy^? = 2-phenylpyridine-2′-yl anion, and bpy = 2,2′-bipyridine have been investigated and compared with those of [M(bpy)₂]²⁺ complexes and of the free protonated ligands H₂bph, Hbpy⁺, and Hphpy. In the absorption spectra, the region below 320 mm is dominated by ligand-centered (LC) transitions, whereas metal-to-ligand charge transfer (MLCT) transitions are responsible for the bands present in the near UV/VIS region. The MLCT bands move to higher energies on replacing Pt with Pd and in going from [M(bph)(bpy)] to the [M(phpy)₂] isomer. For the mixed-ligand complexes, evidence for both M → bph^2? (at higher energies) and M → bpy bands is found. The structured luminescence observed at 77 K shows lifetimes of 4.0 and 1.1 μs for [Pt(phpy)₂] and [Pt(bph)(bpy)], respectively, and 480 and 250 μs for the analogous Pd complexes. On the basis of the energy and lifetime data, the luminescence of the Pt(II) complexes is assigned to the lowest triplet MLCT excited state, whereas for the Pd complexes the luminescent state is thought to result from a mixture of MLCT and LC triplet levels.     

Experimental and Theoretical Studies on DNA‐Binding and Spectral Properties of ‘Light Switch’ Complexes [Ru(L)2(ppn)]2+ (L=2,2′‐Bipyridine and 1,10‐Phenanthroline; ppn=Pteridino[6,7‐f] [1,10]phenanthroline‐11,13‐diamine)

The ligand pteridino[6,7‐f] [1,10]phenanthroline‐11,13‐diamine (ppn) and its Ru^II complexes [Ru(bpy)₂(ppn)]²⁺ ( 1 ; bpy=2,2′‐bipyridine) and [Ru(phen)₂(ppn)]²⁺ ( 2 ; phen=1,10‐phenanthroline) were synthesized and characterized by elemental analysis, electrospray MS, ¹H‐NMR, and cyclic voltammetry. The DNA‐binding behaviors of 1 and 2 were studied by spectroscopic and viscosity measurements. The results indicate that both complexes strongly bind to calf‐thymus DNA in an intercalative mode, with DNA‐binding constants K_b of (1.7±0.4)?10⁶ M ^?1 and (2.6±0.2)?10⁶ M ^?1, respectively. The complexes 1 and 2 exhibit excellent DNA‐‘light switch’ performances, i.e., they do not (or extremely weakly) show luminescence in aqueous solution at room temperature but are strongly luminescent in the presence of DNA. In particular, the experimental results suggest that the ancillary ligands bpy and phen not only have a significant effect on the DNA‐binding affinities of 1 and 2 but also have a certain effect on their spectral properties. [Ru(phen)₂(ppn)]²⁺( 2 ) might be developed into a very prospective DNA‐‘light switch’ complex. To explain the DNA‐binding and spectral properties of 1 and 2 , theoretical calculations were also carried out applying the DFT/TDDFT method.     

Exploiting the versatility of pyridyl ligands for the preparation of diorganotin (IV) adducts: spectral,crystallographic and Hirshfeld surface analysis studies

Diorganotin (IV) complexes SnR₂X₂ (R = Me, Ph; X = Cl, NCS) form a series of versatile complexes when react with bidentate substituted pyridyl ligands. The reaction of dimethyltin dichloride with 5,5′‐dimethyl‐2,2′‐bipyridine (5,5′‐Me₂bpy) resulted in the formation of [SnMe₂Cl₂(5,5′‐Me₂bpy)] ( 1 ). Moreover, the reaction of SnMe₂(NSC)₂ with 4,4′‐di‐tert‐butyl‐2,2′‐bipyridine (bu₂bpy), 1,10‐phenanthroline (phen) and 4,7‐diphenyl‐1,10‐phenanthroline (bphen) affords the hexa‐coordinated complexes [SnMe₂(NCS)₂(bu₂bpy)] ( 2 ), [SnMe₂(NCS)₂(phen)] ( 3 ) and [SnMe₂(NCS)₂(bphen)] ( 4 ), respectively. The resulting complexes have been characterized using elemental analysis, IR, multinuclear NMR (¹H, ¹³C, ¹¹⁹Sn) and DEPT‐135^° NMR spectroscopy. On the other hand, the reaction of diphenyltin dichloride with 2,2′‐biquinoline (biq) and 4,7‐phenantroline (4,7‐phen) led to the formation of polymeric complexes of [SnPh₂Cl₂(4,7‐phen)]_n ( 5 ) and [SnPh₂Cl₂(biq)]_n ( 6 ). The NMR spectra, however, reveal the ligand lability in solution and suggest a coordination number of 5 . The X‐ray crystal structures of complexes [SnMe₂Cl₂(5,5′‐Me₂bpy)] ( 1 ), [SnMe₂(NCS)₂(bu₂bpy)] ( 2 ) and [SnMe₂(NCS)₂(bphen)] ( 4 ) have been determined which reveal that the geometry around the tin atom is distorted octahedral with trans‐[SnMe₂] configuration. Interestingly, the crystal structure of (H₂biq)₂[SnPh₂Cl₄]?2CHCl₃ ( 7 ) was characterized by X‐ray crystallography from a chloroform solution of [SnPh₂Cl₂(biq)]_n ( 6 ) indicating the formation of doubly protonated [H₂biq]⁺ and [Ph₂SnCl₄]^2? which are stabilized by a network of hydrogen bonds with a feature of trans‐[SnPh₂]. The 3D Hirshfeld surface analysis and 2D fingerprint maps were used for quantitative mapping out of the intermolecular interactions for 1 , 2 , 4 and 7 which show the presence of π‐π and hydrogen bonding interactions which are associated between donor and acceptor atoms (N, S, Cl) in the solid state.     

Synthesis,characterization, and DNA binding of ruthenium(II) complexes with 2-benzo[b] furan-2-yl-1H-imidazo[4,5f][1,10]phenanthroline as an intercalative ligand

DNA-binding properties of a number of ruthenium complexes with different polypyridine ligands are reported. The new polypyridine ligand BFIP (=2-benzo[b] furan-2-yl-1H-imidazo[4,5-f][1,10]phenanthroline) and its ruthenium complexes [Ru(bpy)₂BFIP]²⁺ (bpy = 2,2′-bipyridine), [Ru(dmb)₂BFIP]²⁺ (dmb = 4,4′-dimethyl-2,2′-bipyridine), and [Ru(phen)₂BFIP]²⁺ (phen = 1,10-phenanthroline) have been synthesized and characterized by elemental analysis, mass spectra, IR, UV-Vis, ¹H- and ¹³C-NMR, and cyclic voltammetry. The DNA binding of these complexes to calf-thymus DNA (CT-DNA) was investigated by spectrophotometric, fluorescence, and viscosity measurements. The results suggest that ruthenium(II) complexes bind to CT-DNA through intercalation. Photocleavage of pBR 322 DNA by these complexes was also studied, and [Ru(phen)₂BFIP]²⁺ was found to be a much better photocleavage agent than the other two complexes.     

Synthesis,characterization, and cytotoxicity of Pt(IV) complexes containing 1,10-phenanthroline and 2,2′-bipyridine and diaminocyclohexane ligands

Four platinum(IV) complexes containing intercalating ligands [1,10-phenanthroline (phen) and 2,2′-bipyridine (bpy)] and ancillary ligands [(1S,2S)-diaminocyclohexane (SS-DACH) and (1R,2R)-diaminocyclohexane (RR-DACH)] were synthesized and characterized by ¹H nuclear magnetic resonance, electrospray ionization mass spectrometry, X-ray crystal structure analysis, elemental analysis, ultraviolet absorption spectroscopy, circular dichroism spectroscopy, and electrochemical analysis. The reactions between [Pt(phen)(SS-DACH)Cl₂]²⁺ and glutathione and Ac-CPFC-NH₂ were investigated by high-performance liquid chromatography. [Pt(phen)(SS-DACH)Cl₂]²⁺ was reduced to its corresponding Pt(II) complex [Pt(phen)(SS-DACH)]²⁺, while glutathione and Ac-CPFC-NH₂ were oxidized to glutathione-disulfide and a peptide containing an intramolecular disulfide bond, respectively. The cytotoxicities of the Pt(IV) complexes against a human non-small cell lung cancer cell line (A549) and the corresponding cisplatin-resistant cell line (A549cisR) were evaluated. These Pt(IV) complexes showed a higher activity toward A549 and A549cisR than did cisplatin. Also, the cytotoxicities of the Pt(IV) complexes were higher for A549cisR than for A549 cells. Moreover, the cytotoxicities of the (SS-DACH)-liganded platinum complexes were higher than those of the (RR-DACH)-liganded platinum complexes in either A549 or A549cisR cells. Phen-liganded platinum complexes were more cytotoxic than the bpy-liganded platinum complexes. The cytotoxicities of these Pt(IV) complexes had no correlation with reduction potentials.     

Synthesis, characterization, cytotoxic and DNA binding studies of diimine Platinum(II) and Palladium(II) complexes of short hydrocarbon chain ethyldithiocarbamate ligand

Two novel Platinum(II) and Palladium(II) complexes of 2,2′-bipyridine (bpy) with ethyldithiocarbamate (Et-dtc) were synthesized. These complexes were characterized by spectroscopic methods such as ultraviolet-visible, infrared and ¹H NMR as well as conductivity measurements and chemical analysis. In these complexes, the dithiocarbamate ligand coordinates with Pt(II) or Pd(II) center as bidentate with two sulfur atoms. These water soluble complexes were tested for their in vitro anti-tumor activity against chronic myelogenous leukemia cell line, K562. They show Cc₅₀ values lower than those of cisplatin. The mode of binding of the complexes to calf thymus DNA, were investigated by circular dichroism, ultraviolet difference and fluorescence spectroscopy. These complexes can denature DNA at very low concentrations (~100 μM). Both complexes exhibit cooperative binding and presumably intercalate into DNA. Remarkably, most of the experimental results indicate that the tendency of the Pd(II) complex to interact with DNA and its anti-tumor activity against K562 is more than that of its Pt(II) analog.     

Ruthenafuran Complexes Supported by the Bipyridine-Bis(diphenylphosphino)methane Ligand Set: Synthesis and Cytotoxicity Studies

Mononuclear and dinuclear Ru(II) complexes cis-[Ru(κ²-dppm)(bpy)Cl₂] (1), cis-[Ru(κ²-dppe)(bpy)Cl₂] (2) and [Ru₂(bpy)₂(μ-dpam)₂(μ-Cl)₂](Cl)₂ ([3](Cl)₂) were prepared from the reactions between cis(Cl), cis(S)-[Ru(bpy)(dmso-S)₂Cl₂] and diphosphine/diarsine ligands (bpy = 2,2′-bipyridine; dppm = 1,1-bis(diphenylphosphino)methane; dppe = 1,2-bis(diphenylphosphino)ethane; dpam = 1,1-bis(diphenylarsino)methane). While methoxy-substituted ruthenafuran [Ru(bpy)(κ²-dppe)(C^O)]⁺ ([7]⁺; C^O = anionic bidentate [C(OMe)CHC(Ph)O]⁻ chelate) was obtained as the only product in the reaction between 2 and phenyl ynone HC≡C(C=O)Ph in MeOH, replacing 2 with 1 led to the formation of both methoxy-substituted ruthenafuran [Ru(bpy)(κ²-dppm)(C^O)]⁺ ([4]⁺) and phosphonium-ring-fused bicyclic ruthenafuran [Ru(bpy)(P^C^O)Cl]⁺ ([5]⁺; P^C^O = neutral tridentate [(Ph)₂PCH₂P(Ph)₂CCHC(Ph)O] chelate). All of these aforementioned metallafuran complexes were derived from Ru(II)–vinylidene intermediates. The potential applications of these metallafuran complexes as anticancer agents were evaluated by in vitro cytotoxicity studies against cervical carcinoma (HeLa) cancer cell line. All the ruthenafuran complexes were found to be one order of magnitude more cytotoxic than cisplatin, which is one of the metal-based anticancer agents being widely used currently.     

多吡啶钴(Ⅲ)配合物与Zn2+形成的新型“关-开”荧光探针

近十几年来,对小分子过渡金属配合物与大分子DNA键合与识别机理的研究一直是国际上生物无机化学领域十分活跃的研究课题[1￣3],已发展了一系列具有特定功能的配合物,如DNA结构探针和DNA荧光探针等。与其他类型的金属配合物相比,八面体过渡金属多吡啶配合物具有丰富的光化学和光物理信息,当这些配合物与DNA相互作用时,由于结构匹配或微环境的差异,配合物的光谱特征会出现不同程度的改变,从而达到对DNA的检测。传统的DNA荧光探针有[Ru(bpy)2dppz]2 和[Ru(phen)2dppz]2 (bpy=2,2′-联吡啶,phen=1,10-菲咯啉,dppz=二吡啶[3,2-a∶2′,3′…     

Bis(2,2′-bipyridine)cobalt(III) complexes containing asymmetric ligands: Synthesis,DNA-binding and photocleavage studies

Three new Co^III complexes: [Co(bpy)₂(pdtb)]³⁺ (1), [Co(bpy)₂(pdta)]³⁺ (2) and [Co(bpy)₂(pdtp)]³⁺ (3) have been synthesized and characterized. The DNA binding behavior of the Co^III complexes has been investigated by spectroscopic methods and viscosity measurements. The results indicate that the size and shape of the intercalated ligand have a marked effect on the binding affinity of complexes involving CT-DNA. Complexes (2) and (3) have been found to promote cleavage of plasmid pBR 322 DNA from the supercoiled form I to the open circular form II upon irradiation. Photocleavage mechanisms are proposed.     

Bis(4,4′‐bipyridinium) hexa­cyano­platinate(IV) bis­(4,4′‐bipyridine)

In the title compound, (C₁₀H₉N₂)₂[Pt(CN)₆]·2C₁₀H₈N₂ or [(Hbpy)⁺]₂[Pt(CN)₆]²⁻·2bpy, where bpy is 4,4′‐bipyridine, the Hbpy⁺ cations and bpy mol­ecules form a hydrogen‐bonded two‐dimensional cationic approximately square grid parallel to the (110) plane. The [Pt(CN)₆]²⁻ dianions reside in the cavities within this grid, with the nitrile N atoms forming weak hydrogen bonds with the CH groups in the cationic lattice.     

Synthesis,characterization and DNA binding and photocleavage studies of [Ru(bpy)2BDPPZ]2+, [Ru(dmb)2BDPPZ]2+ and [Ru(phen)2BDPPZ]2+ complexes and their antimicrobial activity

Polypyridyl ligand 9a,13a‐dihydro‐4,5,9,14‐tetraaza‐benzo[b]triphenylene‐11‐yl)‐phenyl‐methanone (BDPPZ) and its complexes [Ru(bpy)₂BDPPZ]²⁺, [Ru(dmb)₂BDPPZ]²⁺ and [Ru(phen)₂BDPPZ]²⁺ (where bpy = 2,2′‐bipyridine, dmb = 4,4′‐dimethyl‐2,2′‐bipyridine, phen = 1,10‐phenanthroline) have been synthesized and characterized by elemental analysis, IR, UV–vis, ¹H‐NMR, ¹³C‐NMR and mass spectra. The DNA‐binding properties of the complexes were investigated by absorption, emission, melting temperature and viscosity measurements. Experimental results indicate that the three complexes can intercalate into DNA base pairs. Photo activated cleavage of pBR‐322 DNA by the three complexes was also studied. Further, all three Ru(II) complexes synthesized were screened for their antimicrobial activity. Copyright © 2009 John Wiley & Sons, Ltd.     

Synthesis,DNA-binding and photocleavage studies of cobalt(III) mixed-ligand complexes

Two novel complex ions [Co(bpy)₂IP]³⁺ and [Co(bpy)₂PIP]³⁺, have been prepared and characterized by EA, mass spectra, u.v.–vis., and cyclic voltammetry. The binding behavior of both complexes to calf thymus DNA (CT-DNA) has been investigated by spectroscopic methods, cyclic voltammetry, and viscosity measurements. The results suggest that both complexes bind to DNA by intercalation. Both promote cleavage of plasmid pBR 322 DNA from the supercoiled Form I to the open circular Form II upon irradiation. Mechanisms for photocleavage are proposed.